pISSN 2636-0004eISSN 2636-0012
pISSN 2636-0004Inclusion and Exclusion Criteria
| Inclusion criteria | Exclusion criteria |
|---|---|
| Patients 18–85 years of age | Adenocarcinoma with histological diagnosis of ≥ T1b |
| Informed consent | Pregnancy |
| Patients with a Barrett’s esophagus with a baseline confirmed histological diagnosis of low-grade dysplasia, high-grade dysplasia or T1a adenocarcinoma | Significant oesophageal stenosis prior to initial hybrid-APC treatment defined as a stenosis that cannot be passed by a therapeutic endoscope or a stenosis |
| Patients with incomplete healing post-endoscopic resection despite adequate PPI-medication | |
| Presence of esophageal varices | |
| Anticoagulant therapy that cannot be discontinued prior to hybrid-APC or incorrectable hemostatic disorders | |
| Life expectancy less than 2 years |
APC, argon plasma coagulation; PPI, proton pump inhibitor.